<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Sluijs, J.</title>
    <link>http://repub.eur.nl/res/aut/11971/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department (Article)</title>
      <link>http://repub.eur.nl/res/pub/8880/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>The detailed analysis of 411 strains of coagulase-negative staphylococci
          (CoNS) obtained from 40 neutropenic hemato-oncologic patients (61 Hickman
          catheter episodes) on intensive chemotherapy is described. By random
          amplification of polymorphic DNA (RAPD) analysis, a total of 88 different
          genotypes were detected: 51 in air samples and 30 in skin cultures prior
          to insertion, 12 in blood cultures after insertion, and only 5 involved in
          catheter-related infections (CRI). Two RAPD genotypes of Staphylococcus
          epidermidis predominated, and their prevalence increased during patient
          hospitalization. At insertion, these clones constituted 11 of 86 (13%)
          CoNS isolated from air samples and 33 of 75 (44%) CoNS isolated from skin
          cultures. After insertion, their combined prevalence increased to 33 of 62
          (53%) in catheters not associated with CRI and 139 of 188 (74%) in
          catheters associated with CRI (P = 0.0041). These two predominant S.
          epidermidis clones gave rise to a very high incidence of CRI (6.0 per
          1,000 catheter days) and a very high catheter removal rate for CRI, 70%,
          despite prompt treatment with vancomycin. A likely source of S.
          epidermidis strains involved in CRI appeared to be the skin flora in 75%
          of cases. The validity of these observations was confirmed by pulsed-field
          gel electrophoresis (PFGE) of SmaI DNA macrorestriction fragments of blood
          culture CoNS isolates. Again, two predominant CoNS genotypes were found
          (combined prevalence, 60%). RAPD and PFGE yielded concordant results in
          75% of cases. Retrospectively, the same two predominant CoNS clones were
          also found among blood culture CoNS isolates from the same hematology
          department in the period 1991 to 1993 (combined prevalence, 42%) but not
          in the period 1978 to 1982. These observations underscore the pathogenic
          potential of clonal CoNS types that have successfully and persistently
          colonized patients in this hemato-oncology department.</description>
    </item>
  </channel>
</rss>